The Washington Reporter interviewed CAHC’s Joel White about the Inflation Reduction Act’s unfair treatment of small molecule drugs — typically pills, tablets, and capsules — to government price-setting four years earlier than biologics.
“The Biden IRA has been a nightmare for American patients and is causing sky-rocketing out-of-pocket costs on Pill Penalty prescriptions,” Joel White, president of the Council for Affordable Health Coverage, told the Washington Reporter.
“Joe Biden and Democrats in Congress have forced the drug companies to move away from developing the kinds of drugs patients prefer — because they’re easier to take, more affordable, and more widely available — and these companies are now being pushed toward developing more injectables and IV treatments instead,” White continued.
“These more expensive products are delivered in more expensive settings, raising costs for taxpayers and patients,” he added.